Using generative artificial intelligence (generative AI), scientists from Massachusetts Institute of Technology (MIT) and their collaborators elsewhere designed novel antibiotics capable of combating two challenging infections: drug-resistant Neisseria gonorrhoeae and multi-drug-resistant Staphylococcus aureus (MRSA). Details of the work are published in a new Cell paper titled “A generative deep learning approach to de novo antibiotic design.”
According to the paper, the scientists used generative AI to design more than…